1A型遗传性运动感觉神经病患儿的生活质量 - Suppr

Suppr

超能文献

Quality of life in children with CMT type 1A.

作者信息

Ramchandren Sindhu, Shy Michael E, Finkel Richard S

出版信息

Lancet Neurol. 2009 Oct;8(10):880-1; author reply 881. doi: 10.1016/S1474-4422(09)70247-9.

DOI:10.1016/S1474-4422(09)70247-9

PMID:19747650

Abstract

摘要

相似文献

Quality of life in children with CMT type 1A.

Lancet Neurol. 2009 Oct;8(10):880-1; author reply 881. doi: 10.1016/S1474-4422(09)70247-9.

Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective?

Lancet Neurol. 2009 Dec;8(12):1075-7. doi: 10.1016/S1474-4422(09)70270-4. Epub 2009 Oct 7.

Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial.

Lancet Neurol. 2009 Dec;8(12):1103-10. doi: 10.1016/S1474-4422(09)70260-1. Epub 2009 Oct 7.

Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.

Lancet Neurol. 2009 Jun;8(6):537-44. doi: 10.1016/S1474-4422(09)70108-5. Epub 2009 May 6.

A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].

Pharmacol Res. 2006 Dec;54(6):436-41. doi: 10.1016/j.phrs.2006.09.001. Epub 2006 Sep 9.

Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

Nat Med. 2004 Apr;10(4):396-401. doi: 10.1038/nm1023. Epub 2004 Mar 21.

Ascorbic acid for treatment of CMT1A: the jury is still out.

Lancet Neurol. 2009 Jun;8(6):505-7. doi: 10.1016/S1474-4422(09)70112-7. Epub 2009 May 6.

[Ascorbic acid: a first generation drug for Charcot-Marie-Tooth disease].

Med Sci (Paris). 2004 Oct;20(10):843-4. doi: 10.1051/medsci/20042010843.

Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A.

J Peripher Nerv Syst. 2008 Mar;13(1):64-70. doi: 10.1111/j.1529-8027.2008.00159.x.

[Ascorbic Acid and Charcot-Marie-Tooth Disease].

Brain Nerve. 2015 Oct;67(10):1241-6. doi: 10.11477/mf.1416200289.

引用本文的文献

Validation of the parent-proxy pediatric Charcot-Marie-Tooth disease quality of life outcome measure.

J Peripher Nerv Syst. 2023 Jun;28(2):237-251. doi: 10.1111/jns.12538. Epub 2023 Feb 17.

Validation of the Italian version of the pediatric CMT quality of life outcome measure.

J Peripher Nerv Syst. 2022 Jun;27(2):127-130. doi: 10.1111/jns.12494. Epub 2022 May 3.

Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.

Ann Neurol. 2021 Feb;89(2):369-379. doi: 10.1002/ana.25966. Epub 2020 Dec 7.

Effect of pain in pediatric inherited neuropathies.

Neurology. 2014 Mar 4;82(9):793-7. doi: 10.1212/WNL.0000000000000173. Epub 2014 Jan 29.

Determinants of reduced health-related quality of life in pediatric inherited neuropathies.

Neurology. 2010 Aug 24;75(8):726-31. doi: 10.1212/WNL.0b013e3181eee496.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验